Schizophrenia

Newsletter # 26



Animal models

Schizophrenia is a chronic, severe and disabling brain disorder that affects about 1% of people over the age of 18 years. Patients diagnosed with schizophrenia usually experience multiple symptoms such as hallucinations, delusional thoughts, apathy, lack of emotion, poor social functioning and cognition disorders. Although there is no cure for schizophrenia, current antipsychotic drug helps relieve the symptoms of schizophrenia, but lifelong treatment is usually required.

Psychotomimetic drugs, such as Phencyclidine (angel dust), produce schizophrenia-like symptoms in humans.
In laboratory animals, they induce locomotor hyperactivity which is a widely used method for the screening of antipsychotic drug candidates.

  • Hyperactivity data samples


  • HALOPERIDOL / AMPHETAMINE

    Travelled distance (cm/5min)
  • HALOPERIDOL / AMPHETAMINE

    Total travelled distance (cm/60min)

  • CLOZAPINE / AMPHETAMINE

    Travelled distance (cm/5min)
  • CLOZAPINE / AMPHETAMINE

    Total travelled distance (cm/60min)

  • HALOPERIDOL / MK-801

    Travelled distance (cm/5min)
  • HALOPERIDOL / MK-801

    Total travelled distance (cm/60min)

  • CLOZAPINE / PCP

    Travelled distance (cm/5min)
  • CLOZAPINE / PCP

    Total travelled distance (cm/60min)
  • Catalepsy data samples




NEUROFIT offers a range of validated in vitro and in vivo screening tests for psychiatry and neurology.

If you need further information, please do not hesitate to contact us.
On a regular basis we distribute newsletters with scientific information on our research services. If you wish to receive these, please sign up on our mailing list:


e-mail :


Field of interrest :